Pregabalin clinical trials

Explore recruiting pregabalin clinical trials.

Recruiting pregabalin studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pregabalin trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Sleep structure in neuropathic pain patients, psychological factors, brain connectivity, and the effect of pregabalin on sleep and pain

Finland

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2, Randomized, Double-blind, Active-controlled, Dose-ranging, Parallel-design Study of the Efficacy and Safety of Oral VX-993 in Subjects With Painful Diabetic Peripheral Neuropathy

France, Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Unravelling the local and systemic effects of primary surgery and perioperative use of ketorolac and pregabalin in primary breast cancer patients according to adiposity

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Investigation of pregabalin therapy and complex rehabilitation in treating chronic fatigue associated with post-COVID syndrome

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomised, crossover bioequivalence clinical trial of pregabalin 300 mg tablets versus pregabalin 300 mg hard capsules, after a single oral dose administration to healthy volunteers under fasting conditions.

Spain

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Pregabalin or Baclofen in Spastic Motor Behavior Treatment After SCI (PoBSCI), Prospective, Double-Blind, Randomised Drug Study

Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pregabalin trials by city

Pregabalin in Toronto Pregabalin in Vancouver Pregabalin in Montreal Pregabalin in Calgary Pregabalin in Edmonton Pregabalin in Ottawa Pregabalin in Winnipeg Pregabalin in Quebec City Pregabalin in Hamilton Pregabalin in Kitchener Pregabalin in London Pregabalin in Halifax Pregabalin in New York Pregabalin in Los Angeles Pregabalin in Chicago Pregabalin in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease